Byrne Lee

6PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPlasma physics; fusion plasmas; electrical discharges
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2026
ASO Visual Abstract: Efficacy and Safety of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Uterine Leiomyosarcoma: Results of a Phase 2 Study.

|May 08, 2026
Efficacy and Safety of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Uterine Leiomyosarcoma: Results of a Phase 2 Study.

|Aug 05, 2025
ASO Visual Abstract: Understanding Curability and Life Expectancy in Surgical Patients with Advanced Cancer: A Mixed Methods Analysis of Factors that Affect Views on Cancer Prognosis.

Beatrice J Sun, Emily M Pang, Tiffany M Yue

|Jul 07, 2025
Understanding Curability and Life Expectancy in Surgical Patients with Advanced Cancer: A Mixed Methods Analysis of Factors that Affect Views on Cancer Prognosis.

Beatrice J Sun, Emily M Pang, Tiffany M Yue

|Mar 11, 2024
Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).

Tiffany M Yue, Beatrice J Sun, Nova Xu

|Sep 28, 2023
Results of the First Phase I PIPAC Trial in the United States: Braving the Storm.

Beatrice J Sun, Byrne Lee

Pageof 1

Frequent Collaborators